Fact CheckerSign in

NCT05548413Recruiting

Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies

Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies in Patients With Heart Failure

Source: ClinicalTrials.gov · Last updated 5 May 2026

Brief summary (registry, in English)

People with heart failure who do not take their medications as prescribed are at high risk of complications leading to hospitalization, death and poor quality of life. In the proposed intervention, nurses will use easy-to-understand language to coach patients and their care partners to help them work together and build skills to overcome their individual barriers to adherence in order to 1) improve and sustain patient medication adherence; 2) reduce hospitalization; 3) improve quality of life. If effective, this intervention will support long-term medication adherence, thus reducing hospitalizations related to heart failure and quality of life.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
328 (estimated)
First submitted
16 Sept 2022
Start date
4 Jan 2023
Primary completion date
30 Jun 2027
Lead sponsor
Jia-Rong Wu
NCT number
NCT05548413

What you commit to

  • Study type: Interventional
  • Planned participants: 328
  • From 4 Jan 2023 to the primary completion date, 30 Jun 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • currently or have received any similar self-care intervention recently in the past year

Other illness

  • cognitive impairment as indicated by having difficulties to understand and give informed consent
  • co-existing end-stage renal disease or terminal illness such as advanced malignancy, or any other condition with less than 1-year life expectancy
  • psychotic illness
  • cognitive impairment as indicated by having difficulties to understand and give informed consent
  • coexisting terminal illness

Other

  • a recent hospitalization within 3 months of study enrollment
  • current alcohol dependence or other substance abuse
  • inability to speak English or other communication barrier
  • non-English speaking or any other communication barrier

Who the study is looking for

  • confirmed diagnosis of heart failure (HF), either systolic or diastolic HF
  • ave suboptimal medication adherence
  • have a care partner (CP) (either spouse, daughter/son, partner, other relative, friend) who is identified by the patient as the person most involved in HF care
  • willingness to have a CP be involved in their medication taking
  • have undergone evaluation of HF and prescribed stable doses of HF medications for at least 3 months
  • live in a setting where the patient is responsible for their ow medication administration
  • willing to use the SimpleMed+ (i.e., an electronic pillbox to measure objective medication adherence)
  • availability by phone
  • unpaid family member, friend, partner, or other relation who is involved in the patients' care at least 3 times a week, designated by the patient
  • willing to receive interventions with the patient together
  • 18 years of age or older

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Jia-Rong Wu
Coordinator of this site? Confirm its status
LexingtonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.